Skip to main content
English

Publikationen

Musculosceletal Tumor Unit (CCC-MST)
  1. Comprehensive Cancer Center
  2. Forschung
  3. CCC-Units
  4. Musculosceletal Tumor Unit
  5. Forschung
  6. Publikationen
Pubmed-Search: Neueste Publikationen MST-Mitglieder
  • Kager L, Kempf-Bielack B, Bielak S. Synchronous and metachronous lung metastases in high-grade osteosarcoma. Jpn J Clin Oncol. 2010 Jan;40(1):94-5
  • Aryee DN, Niedan S, Kauer M, Schwentner R, Bennani-Baiti IM, Ban J, Muehlbacher K, Kreppel M, Walker RL, Meltzer P, Poremba C, Kofler R, Kovar H. Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro. Cancer Res. 2010;70(10):4015-23.
  • Le Deley MC, Delattre O, Schaefer KL, Burchill SA, Koehler G, Hogendoorn PC, Lion T, Poremba C, Marandet J, Ballet S, Pierron G, Brownhill SC, Nesslböck M, Ranft A, Dirksen U, Oberlin O, Lewis IJ, Craft AW, Jürgens H, Kovar H. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol. 2010 Apr 20;28(12):1982-8.
  • Bennani-Baiti IM, Cooper A, Lawlor ER, Kauer M, Ban J, Aryee DN, Kovar H. Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma. Clin Cancer Res. 2010 Jul 15;16(14):3769-78
  • Ladenstein R, Pötschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, van den Berg H, Dirksen U, Hjorth L, Michon J, Lewis I, Craft A, Jürgens H. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol. 2010 Jul 10;28:3284-91
  • Lamm W, Amann G, Brodowicz T. Case Reports in Oncology: Case report of suspected rhabdomyolysis during treatment with trabectedin in a patient with metastatic leiomyosarcoma. Case Rep Oncol. 2010 Sep;3(3):477-9.
  • Fakhrai N, Ebm C, Köstler WJ, Jantsch M, Abdolvahab F, Dominkus M, Pokrajac B, Kauer-Dorner D, Zielinski CC, Brodowicz T; Austrian Cooperative Soft Tissue Sarcoma Study Group. Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial. Wien Klin Wochenschr 2010 Nov; 122(21-22):614-9.
  • Funovics PT, Vaselic S, Panotopoulos J, Kotz RI, Dominkus M. The impact of re-excision of inadequately resected soft tissue sarcomas on surgical therapy, results, and prognosis: A single institution experience with 682 patients. J Surg Oncol. 2010 Nov 1;102(6):626-33.
  • Kager L, Zoubek A, Dominkus M, Lang S, Bodmer N, Jundt G, Klingebiel T, Jürgens H, Gadner H, Bielack S; COSS Study Group. Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group. Cancer. 2010 Nov 15;116(22):5316-24.
  • Kager L, Pötschger U, Bielack S. Review of mifamurtide in the treatment of patients with osteosarcoma. Ther Clin Risk Manag. 2010;6:279-86.
  • Sulzbacher I, Birner P, Dominkus M, Pichlhofer B, Mazal PR. Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome. Pathology. 2010 Dec;42(7):664-8.
  • Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, Windhager R, Kotz RI, Mercuri M, Funovics PT, Hornicek FJ, Temple HT, Ruggieri P, Letson GD. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am. 2011 Mar 2;93(5):418-29.
  • Alireza Hoda M, Mohamed A, Ghanim B, Filipits M, Hegedus B, Tamura M, Berta J, Kubista B, Dome B, Grusch M, Setinek U, Micksche M, Klepetko W, Berger W. Temsirolimus Inhibits Malignant Pleural Mesothelioma Growth in Vitro and in Vivo: Synergism with Chemotherapy. J Thorac Oncol. 2011;6(5):852-63.
  • Andreou D, Bielack SS, Carrle D, Kevric M, Kotz R, Winkelmann W, Jundt G, Werner M, Fehlberg S, Kager L, Kühne T, Lang S, Dominkus M, Exner GU, Hardes J, Hillmann A, Ewerbeck V, Heise U, Reichardt P, Tunn PU. The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Ann Oncol. 2011 May;22(5):1228-35.
  • Ban J, Jug G, Mestdagh P, Schwentner R, Kauer M, Aryee DN, Schaefer KL, Nakatani F, Scotlandi K, Reiter M, Strunk D, Speleman F, Vandesompele J, Kovar H. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma. Oncogene. 2011 May 5;30(18):2173-80.
  • Funovics PT, Bucher F, Toma CD, Kotz RI, Dominkus M. Treatment and outcome of parosteal osteosarcoma: Biological versus endoprosthetic reconstruction. J Surg Oncol. 2011 Jun;103(8):782-9
  • Funovics PT, Schuh R, Adams SB, Sabeti-Aschraf M, Dominkus M, Kotz RI. Modular prosthetic reconstruction of major bone defects of the distal end of the humerus. J Bone Joint Surg Am. 2011 Jun 1;93(11):1064-74.
  • Nierlich P, Funovics P, Dominkus M, Aszmann O, Frey M, Klepetko W. Forequarter amputation combined with chest wall resection: a single-center experience. Ann Thorac Surg. 2011 Jun;91(6):1702-8.
  • Funovics PT, Panotopoulos J, Sabeti-Aschraf M, Abdolvahab F, Funovics JM, Lang S, Kotz RI, Dominkus M. Low-grade chondrosarcoma of bone: experiences from the Vienna Bone and Soft Tissue Tumour Registry. Int Orthop. 2011 Jul;35(7):1044-56.
  • Bennani-Baiti IM, Aryee DN, Ban J, Machado I, Kauer M, Mühlbacher K, Amann G, Llombart-Bosch A, Kovar H. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. J Pathol. 2011 Nov;225(3):353-63. doi: 10.1002/path.2966.
  • Bennani-Baiti IM, Machado I, Llombart-Bosch A, Kovar H. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma. Human. Pathol. 2011;in press.
  • Funovics PT, Edelhauser G, Funovics MA, Laux C, Berzaczy D, Kubista B, Kotz RI, Dominkus M. Pre-operative serum C-reactive protein as independent prognostic factor for survival but not infection in patients with high-grade osteosarcoma. Int Orthop. 2011 Oct;35(10):1529-36.
  • Funovics PT, Hipfl C, Hofstaetter JG, Puchner S, Kotz RI, Dominkus M. Management of septic complications following modular endoprosthetic reconstruction of the proximal femur. Int Orthop. 2011 Oct;35(10):1437-44.
  • Schur S, Wild J, Amann G, Köstler W, Langer M, Brodowicz T.
    Sarcoma of the ewing family in pregnancy: a case report of intrauterine fetal death after induction of chemotherapy.
    Case Rep Oncol. 2012;5(3):633-8.
  • Sevcenco S, Kuehhas FE, Heinz-Peer G, Köstler W, Susani M, Haitel A, Klingler HC. Solitary osteoclast-like giant cell tumor of the kidney: a case report. Urology. 2012 80(5):e67-8.
  • Reichardt P, Blay JY, Boukovinas I, Brodowicz T, Broto JM, Casali PG, Decatris M, Eriksson M, Gelderblom H, Kosmidis P, Le Cesne A, Pousa AL, Schlemmer M, Verweij J, Joensuu H. Adjuvant therapy in primary GIST: state-of-the-art. Ann Oncol. 2012;23(11):2776-81.
  • Demetri GD, Le Cesne A, Chawla SP, Brodowicz T, Maki RG, Bach BA, Smethurst DP, Bray S, Hei YJ, Blay JY. First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study. Eur J Cancer. 2012;48(4):547-63.
  • Brodowicz T, Amann G, Leithner A, Sztankay A, Kainberger F, Eisterer W, Liegl-Atzwanger B, Rachbauer F, Rath T, Bergmann M, Funovics PT, Ploner F, Windhager R. [Consensus diagnosis and therapy of soft tissue sarcoma]. Wien Klin Wochenschr. 2012;124(3-4):85-99.
  • Locker GJ, Fuchs EM, Worel N, Bojic A, Heinrich G, Brodowicz T, Clodi M, Funk GC, Knöbl P, Zielinski CC, Köstler WJ.Whole body hyperthermia by extracorporeal circulation in spontaneously breathing sarcoma patients: hemodynamics and oxygen metabolism.
    Int J Artif Organs. 2011 34(11):1085-94.